Author Biographies

N/A
N/A
Joellen M. Schildkraut, Ph.D., MPH, is a professor in the Department of Epidemiology at the Rollins School of Public Health. Dr. Schildkraut is a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute of Emory University in Atlanta, Georgia. Schildkraut received both her MPH and Ph.D. from Yale University. Her doctoral dissertation and early publications focused on the genetic overlap between breast and ovarian cancer through an examination of family history. This work indirectly contributed to the discovery of BRCA1 and BRCA2, the two highly penetrant genes associated with increased risk of breast and ovarian cancers. Schildkraut has studied for much of her career the genetic epidemiology of ovarian, breast, and brain tumors, for which she has utilized innovative technologies and data science approaches to reconsider the biology and epidemiology of these diseases.
Siddhartha P. Kar studied medicine at the Byramjee Jeejeebhoy Government Medical College and trained at the Sassoon General Hospitals in Pune, India. He holds an MPH degree from the University of Texas at Houston in the US and a PhD from the University of Cambridge in the UK, where he was a Gates Cambridge Scholar between 2012 and 2015. His scientific training has also included research stints at the MD Anderson Cancer Center in Houston, Texas (2010–2012) and as a Junior Research Fellow at Homerton College, Cambridge (2015–2019). Siddhartha was awarded a Future Leaders Fellowship by UKRI in 2020 which enabled him to establish his independent research group within the Medical Research Council (MRC) Integrative Epidemiology Unit at the University of Bristol. He returned to Cambridge as a Group Leader at the Early Cancer Institute in the Department of Oncology in March 2023. The Kar group primarily studies inherited or germline genetic variation and leverages this variation to investigate the causes, consequences, and correlates of key somatic or tumor genomic aberrations responsible for driving cancer development and progression.
clear